Since the number of copies of WT1 mRNA (WT1cn) correlates well with the burden of acute myeloid leukemia (AML), WT1cn has been used as a reliable marker of residual AML cells [4, 5, 6]. The gene discussed is WT1; the disease is acute myeloid leukemia.